| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8737573 | Human Immunology | 2018 | 37 Pages |
Abstract
Overall, sCD30 levels are lower in SRL-treated patients, but the association between increased sCD30 levels and IF/TA at month-24 post-transplantation is stronger in SRL than in TAC-treated patients.
Keywords
CNISRLIF/TAEVRDGFDSAPREDTACMycophenolate sodiummTORsCD30MFIPBMCEGFRADAMEverolimusBiomarkerdelayed graft functionTacrolimusperipheral blood mononuclear cellsSirolimusconfidence intervalinterstitial fibrosis/tubular atrophySoluble CD30calcineurin inhibitormean fluorescence intensityestimated glomerular filtration ratehazard ratioMPsPrednisoneKidney transplantation
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Patricia Cristina Grenzi, Ãrika Fernandes Campos, Hélio Jr, Claudia Rosso Felipe, Maria Fernanda Soares, José Medina-Pestana, Hinrich Peter Hansen, Maria Gerbase-DeLima,